CALCATERRA, ILENIA LORENZA
 Distribuzione geografica
Continente #
AS - Asia 2.208
NA - Nord America 1.626
EU - Europa 1.337
SA - Sud America 242
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.462
Nazione #
US - Stati Uniti d'America 1.560
SG - Singapore 952
RU - Federazione Russa 632
CN - Cina 443
VN - Vietnam 373
IT - Italia 339
BR - Brasile 175
HK - Hong Kong 162
FR - Francia 82
DE - Germania 80
IN - India 55
JP - Giappone 50
GB - Regno Unito 44
KR - Corea 37
FI - Finlandia 34
BD - Bangladesh 31
NL - Olanda 31
CA - Canada 30
MX - Messico 25
AR - Argentina 23
UA - Ucraina 18
ID - Indonesia 16
ZA - Sudafrica 16
AT - Austria 15
TH - Thailandia 15
EC - Ecuador 12
CI - Costa d'Avorio 11
IQ - Iraq 11
PL - Polonia 9
TW - Taiwan 9
VE - Venezuela 9
PH - Filippine 8
PK - Pakistan 8
CO - Colombia 7
ES - Italia 7
IE - Irlanda 7
PY - Paraguay 7
SE - Svezia 7
DZ - Algeria 6
GR - Grecia 6
CH - Svizzera 5
JO - Giordania 5
LT - Lituania 5
TR - Turchia 5
AZ - Azerbaigian 3
KE - Kenya 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
NP - Nepal 2
OM - Oman 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
SO - Somalia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
YE - Yemen 1
Totale 5.462
Città #
Singapore 486
San Jose 308
Ashburn 185
Hefei 171
Hong Kong 157
Moscow 140
Ho Chi Minh City 133
Chandler 114
Beijing 97
Hanoi 83
Naples 82
Santa Clara 80
Lauterbourg 50
Los Angeles 48
Boardman 43
Tokyo 43
Dallas 37
Millbury 37
The Dalles 37
Buffalo 31
Seoul 30
Lawrence 29
New York 28
Des Moines 23
Council Bluffs 21
Munich 19
Amsterdam 17
Helsinki 17
Redondo Beach 17
Orem 16
Frankfurt am Main 15
Haiphong 15
Seattle 15
Da Nang 14
Napoli 14
São Paulo 13
Boston 12
Milan 12
Nuremberg 12
Turku 12
Castel Volturno 9
Houston 9
Hải Dương 9
Pune 9
Rio de Janeiro 9
Washington 9
Denver 8
Düsseldorf 8
Montreal 8
Portsmouth 8
Sorrento 8
Wilmington 8
Brooklyn 7
Chennai 7
San Francisco 7
Stockholm 7
Toronto 7
Warsaw 7
Belo Horizonte 6
Changsha 6
Mexico City 6
Shanghai 6
Woodbridge 6
Baghdad 5
Biên Hòa 5
Falkenstein 5
Florence 5
Formia 5
London 5
Manchester 5
Marsala 5
Ottawa 5
Palermo 5
Rome 5
Xi'an 5
Zurich 5
Amman 4
Asunción 4
Atlanta 4
Belvedere Marittimo 4
Bologna 4
Brasília 4
Can Tho 4
Curitiba 4
Dhaka 4
Dublin 4
Ercolano 4
Fairfield 4
Johannesburg 4
Lappeenranta 4
Mumbai 4
Nanjing 4
New Delhi 4
Quito 4
Thái Bình 4
Vienna 4
Afragola 3
Bexley 3
Chiang Mai 3
Chicago 3
Totale 3.044
Nome #
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 151
Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia 147
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 145
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 144
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 141
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 137
Carotid Atherosclerosis, Ultrasound and Lipoproteins 130
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 126
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 124
Clinical assessment of endothelial function in heart failure with preserved ejection fraction: A meta-analysis with meta-regressions 124
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 123
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 122
Clinical assessment of endothelial function in convalescent covid-19 patients undergoing multidisciplinary pulmonary rehabilitation 121
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 121
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 120
Treatment with pcsk9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: A combined metabolomic and lipidomic approach 120
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 117
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 117
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 117
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 116
An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab 115
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 114
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 114
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 112
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 112
Vascular effects of the polyphenolic nutraceutical supplement taurisolo®: Focus on the protection of the endothelial function 112
Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: A systematic review with meta-analysis.: VTE recurrence and D-dimer 111
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 110
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 109
Persistent endothelial dysfunction in post-acute covid-19 syndrome: A case-control study 109
Risk assessment and antithrombotic strategies in antiphospholipid antibody carriers 104
Homozygous Familial Hypercholesterolemia in Campania 103
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 103
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies 101
Post-Bariatric Hypoglycemia Is Associated with Endothelial Dysfunction and Increased Oxidative Stress 100
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies 98
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 94
Alirocumab in high cardiovascular risk patients with Heterozygous Familial Hypercholesterolemia: Efficacy and safety in lipid lowering levels 82
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target 80
SHORT-TERM VARIABILITY OF 24-H SYSTOLIC BLOOD PRESSURE IS ASSOCIATED WITH MICROALBUMINURIA IN PATIENTS WITH PRIMARY HYPERTENSION 76
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies 75
Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study 75
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis 73
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions 73
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model 71
Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials 66
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter study 64
Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients 63
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art 62
Metabolic syndrome in hypertensive patients: An unholy alliance 61
Effects of Mediterranean Diet on Endothelial Reactivity in Individuals with High Cardiometabolic Risk: A Randomized Controlled Parallel-Group Preliminary Trial 61
Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension 55
Acquired Hemophilia A in a Case of Relapsed Immune Thrombotic Thrombocytopenic Purpura 43
Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease 42
Genetic Assessment and Clinical Correlates in Severe Hypertriglyceridemia: A Systematic Review 17
Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A 13
A Rare Case of Acquired Non-neutralizing Factor II Inhibitor in a Patient with B-Cell Lymphoproliferative Disorder. 8
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis 4
Preferences Among Expert Physicians in Areas of Uncertainty in Venous Thromboembolism Management: Results from a Multiple-Choice Questionnaire. 4
Totale 5.552
Categoria #
all - tutte 17.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022231 0 7 7 0 11 11 1 7 3 22 92 70
2022/2023267 30 19 11 8 39 33 3 40 38 17 18 11
2023/2024306 22 35 19 19 18 65 3 22 2 6 28 67
2024/20251.570 58 54 37 69 23 122 149 103 78 193 551 133
2025/20263.084 318 295 349 291 503 96 329 161 393 239 92 18
Totale 5.552